Skip to main content
Let's spread the word about Immunotherapy! Click to share this page with your community.

Immuno-Oncology: A Future Look

This intimate, invitation-only event for media and health care investment analysts will be hosted by Cancer Research Institute at the New York Academy of Sciences. It will feature both a panel of leading academic scientific experts in immunotherapy, including 2018 Nobel Prize winner and Director of CRI’s Scientific Advisory Council, Dr. James P. Allison, and a fireside chat with chief science officers representing pharma and biotech leaders to share their points of view on what’s next in the IO field.

When

Friday, June 21, 2019
Registration: 9am
Panel Sessions: 10am-12pm
Lunch Reception: 12pm

Where

The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, Floor 40
New York, NY 10007

Academic Panel

James P. Allison, Ph.D., 2018 Nobel Laureate
Chair, Department of Immunology, University of Texas MD Anderson Cancer Center

Philip D. Greenberg, M.D.
Head of Immunology, Fred Hutchinson Cancer Research Center

Robert H. Vonderheide, M.D., D.Phil.
Director, Abramson Cancer Center, University of Pennsylvania

Jill O'Donnell-Tormey, Ph.D. (Moderator)
CEO and Director of Scientific Affairs, Cancer Research Institute

Industry Fireside Chat

George D. Yancopoulos, M.D., Ph.D.
Founder, President, and Chief Scientific Officer, Regeneron

Awny Farajallah, M.D., FACP
Vice President, Head U.S. Medical, Bristol-Myers Squibb

Special Guest Moderator

Opening Remarks

Andrew K. Tsai
Co-Chairman, CRI Board of Trustees
Co-Founder and Chief Investment Officer, Chalkstream Capital Group

*Immunotherapy results may vary from patient to patient.

Top